Hemoglobin, platelets, bleeding, pericardial effusions, and intrapulmonary shunting top the monitoring list for patients with pulmonary arterial hypertension (PAH) starting with sotatercept, according to Vallerie McLaughlin, MD.
|Articles|May 6, 2022
Daily OTC Pearl: Relief Factor
Author(s)Saro Arakelians, PharmD
Relief Factor is a supplement that seeks to help users reduce body pains associated with daily living, aging, and exercise.
Advertisement
OTC/Lifestyle Pearl of the Day: Relief Factor
Indication: Relief Factor is a supplement that seeks to help users reduce body pains associated with daily living, aging, and exercise.
Insight:
- Serving Size: 1 packet (containing 2 capsules and 2 softgels).
- Contains epimedium, turmeric, Japanese knotweed extract
- Provides 900 mg of total omega-3 fatty acids.
- Reduce pain associated with aging and joint pain.
Source:
Advertisement
Related to this article
Marie-Claire Seeley, RN, MNurs, PhD, discusses standing tests, medication review, and what inflammatory findings may mean for future POTS treatment.
AI-driven coding fuels specialty EHRs and telehealth tools, making ePrescribing faster, tailored, and affordable while shifting focus to workflow and compliance.
Approval spans early and levodopa-treated disease; a 6-week titration and CYP3A interactions put pharmacists at the center of starting therapy.
Novo Nordisk's top-line phase 3 data show 12.4% weight loss with CagriSema 1.0 mg/1.0 mg in type 2 diabetes and 21.0% in adults with overweight or obesity.
Researchers found substantial overlap in autonomic symptoms, orthostatic tachycardia, and functional impairment between long COVID and POTS.
A review of 69 studies finds influenza vaccines continue to reduce hospitalization and death, with no new safety concerns.
Isatuximab plus Iberdomide maintenance helps MRD-positive myeloma patients turn MRD-negative after transplant, with manageable safety.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Tavapadon, First D1/D5 Agonist for Parkinson Disease
2
Pharmacists Can Close CKD Medication Adherence Gaps, PHTI Says
3
CagriSema Tops Tirzepatide 5 mg for Weight Loss in REIMAGINE 5
4
FDA Approves Tiratricol, First Treatment for MCT8 Deficiency
5